Daniel Zabrowski
Vorsitzender bei Nimble Therapeutics, Inc.
Vermögen: 1 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Xiao Dong Yang | M | 64 |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | 14 Jahre |
| Peter Colabuono | M | - |
Decheng Capital LLC
 Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.
Ariagen, Inc.
 Ariagen, Inc. Financial ConglomeratesFinance Ariagen, Inc. provides investment services. The CEO of the American company is Peter Colabuono. | 8 Jahre |
| Shengrong Lin | M | - |
AccuraGen, Inc.
 AccuraGen, Inc. BiotechnologyHealth Technology AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA. | 11 Jahre |
| Xiang Ming Cui | M | 55 |
Ariagen, Inc.
Ariagen, Inc. Financial ConglomeratesFinance Ariagen, Inc. provides investment services. The CEO of the American company is Peter Colabuono.
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China.
AccuraGen, Inc.
AccuraGen, Inc. BiotechnologyHealth Technology AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA. | - |
| Galit Frydman | M | - |
Coagulo Medical Technologies, Inc.
 Coagulo Medical Technologies, Inc. Information Technology ServicesTechnology Services Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA. | - |
| Kang Ying | M | - |
AccuraGen, Inc.
AccuraGen, Inc. BiotechnologyHealth Technology AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA. | 11 Jahre |
| Matthias Steger | M | - |
Endogena Therapeutics, Inc.
 Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA. | - |
| Scott Smith | M | 61 |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | 5 Jahre |
| Daniel Schmitt | M | 62 |
Actuate Therapeutics, Inc.
| 9 Jahre |
| Jakob Dupont | M | 58 |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | 4 Jahre |
| Gordon Ringold | M | 73 |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | 4 Jahre |
| Jigar Patel | M | - |
Nimble Therapeutics, Inc.
 Nimble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI. | 5 Jahre |
| Francis Sarena | M | 53 |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | 2 Jahre |
| Brendan Delaney | M | 49 | 3 Jahre | |
| Susan Volkert | F | - |
Coagulo Medical Technologies, Inc.
Coagulo Medical Technologies, Inc. Information Technology ServicesTechnology Services Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA. | - |
| Jarrod Niebloom | M | - |
Coagulo Medical Technologies, Inc.
Coagulo Medical Technologies, Inc. Information Technology ServicesTechnology Services Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA. | 6 Jahre |
| Andrew Mazar | M | 62 |
Actuate Therapeutics, Inc.
| 9 Jahre |
| Aaron Fletcher | M | 44 |
Actuate Therapeutics, Inc.
| 9 Jahre |
| Kelly Perez | F | - |
Omniome LLC
 Omniome LLC Miscellaneous Commercial ServicesCommercial Services Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA. | 7 Jahre |
| Richard P. Lifton | M | 71 | 9 Jahre | |
| Paul Tang | M | - |
AccuraGen, Inc.
AccuraGen, Inc. BiotechnologyHealth Technology AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA. | 11 Jahre |
| Todd Thomson | M | 63 |
Actuate Therapeutics, Inc.
| 2 Jahre |
| Amy Wong | F | 58 |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | 10 Jahre |
| Bernard Poussot | M | 72 | 9 Jahre | |
| Shawn M. Marcell | M | 62 |
Coagulo Medical Technologies, Inc.
Coagulo Medical Technologies, Inc. Information Technology ServicesTechnology Services Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA. | - |
| William J. Rutter | M | - |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | - |
| Derek Lee | M | - |
Coagulo Medical Technologies, Inc.
Coagulo Medical Technologies, Inc. Information Technology ServicesTechnology Services Coagulo Medical Technologies, Inc. engages in the provision of precision-medicine platform for coagulation management. The company was founded by Galit Frydman and is headquartered in Auburndale, MA. | - |
| Malek Faham | M | - |
AccuraGen, Inc.
AccuraGen, Inc. BiotechnologyHealth Technology AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA. | 9 Jahre |
| Gisbert Schneider | M | - |
Endogena Therapeutics, Inc.
Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA. | - |
| Aaron Weaver | M | 43 |
Endogena Therapeutics, Inc.
Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA. | - |
| Wei Xu | M | - |
AccuraGen, Inc.
AccuraGen, Inc. BiotechnologyHealth Technology AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA. | - |
| Weizhi Aaron Li | M | - |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | 6 Jahre |
| Claire Chin | F | - |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | 8 Jahre |
| Xiaohang Tong | M | - |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | 10 Jahre |
| Wei Xu | M | 55 |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | 7 Jahre |
| Qiang Xu | M | - |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | 13 Jahre |
| Nick Pliam | M | - |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | 13 Jahre |
| Victor E Tong | M | - |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | 13 Jahre |
| Yang Lu | M | - |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | 5 Jahre |
| John Tan | M | - |
Nimble Therapeutics, Inc.
Nimble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI. | 5 Jahre |
| Elona Baum | F | - |
Endogena Therapeutics, Inc.
Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Endogena Therapeutics, Inc. develops endogenous regenerative medicines. The company was founded by Matthias Steger and Gisbert Schneideri and is headquartered in San Francisco, CA. | 10 Jahre |
| Rob Hart | M | - |
Nimble Therapeutics, Inc.
Nimble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI. | 5 Jahre |
| Mark Nevins | M | - |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | - |
| Ting Xie | M | - |
Omniome LLC
Omniome LLC Miscellaneous Commercial ServicesCommercial Services Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA. | - |
| Boris Nikolic | M | 54 |
Omniome LLC
Omniome LLC Miscellaneous Commercial ServicesCommercial Services Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA. | - |
| Patricia Lorusso | M | - |
Actuate Therapeutics, Inc.
| 9 Jahre |
| Meenu Chhabra Karson | F | 51 |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | 2 Jahre |
| Kevin Liu | M | - |
AccuraGen, Inc.
AccuraGen, Inc. BiotechnologyHealth Technology AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA. | - |
| David Cruikshank | M | - |
Omniome LLC
Omniome LLC Miscellaneous Commercial ServicesCommercial Services Omniome, Inc. provides biotechnical research services. The firm's biosensors can be adopted for mobile diagnostics and health monitoring applications. The company was founded by Kandaswamy Vijayan in 2013 and is headquartered in San Diego, CA. | - |
| Ovid C. Trifan | M | - |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | 10 Jahre |
| Deval Lashkari | M | 58 |
Nimble Therapeutics, Inc.
Nimble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI. | - |
| Johnny Sun | M | - |
AccuraGen, Inc.
AccuraGen, Inc. BiotechnologyHealth Technology AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA. | 11 Jahre |
| Paul Grossman | M | 63 |
Nimble Therapeutics, Inc.
Nimble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nimble Therapeutics, Inc. provides drug discovery services using chemical synthesis. It enables the synthesis and screening of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. The company was founded by Jigar Patel and is headquartered in Madison, WI. | - |
| Grace Zhao | M | - |
AccuraGen, Inc.
AccuraGen, Inc. BiotechnologyHealth Technology AccuraGen, Inc. engages in cancer diagnostic and research. It develops sequencing-based cancer-mutation detection systems. The company was founded by Shengrong Lin, Kang Ying, Johnny Sun, Paul Tang and Grace Zhao in 2013 and is headquartered in Menlo Park, CA. | 11 Jahre |
| Yu Katherine Xu | M | 52 |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC is a venture capital firm founded by Min Cui in 2011 having headquartered at Shanghai, China. | 5 Jahre |
| Les Kreis | M | - |
Actuate Therapeutics, Inc.
| - |
| Silke Hörnstein | F | 49 | 9 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Herbert Cross | M | 52 |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | 4 Jahre |
| David A. Graham | M | - |
Indiana University
| 9 Jahre |
| Lori G. Roberts | F | 63 |
Indiana University
| 7 Jahre |
| Rob Barnard | M | 56 |
Indiana University
| 7 Jahre |
| Martin Brena | M | - |
Actuate Therapeutics, Inc.
| 2 Jahre |
| Jeffrey Vacirca | M | 55 | 2 Jahre | |
| Frank Hsu | M | 63 | - | |
| Sarvjeev S. Sidhu | M | - |
Indiana University
| 4 Jahre |
| Greg S. Norrod | M | - |
Indiana University
| 3 Jahre |
| Elisabeth K. Evans | F | 61 |
Indiana University
| 6 Jahre |
| John Inwood | M | - |
Indiana University
| 4 Jahre |
| Quan Qi Song | M | 59 | 5 Jahre | |
| Keith Woodward | M | 60 |
Indiana University
| 4 Jahre |
| Elizabeth O'Farrell | F | 59 |
Indiana University
| 5 Jahre |
| Daniel Peterson | M | - |
Indiana University
| 7 Jahre |
| Anand Deshpande | M | 62 |
Indiana University
| 4 Jahre |
| Meenu Karson | F | 52 | 1 Jahre | |
| Bruce E. Beerbower | M | - |
Indiana University
| 5 Jahre |
| William Burns | M | 76 | 4 Jahre | |
| William Duke | M | 51 | 1 Jahre | |
| Kenneth Fong | M | - |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | - |
| Jong-Suk Ye | M | 70 |
Indiana University
| 3 Jahre |
| Gregory S. Davis | M | 62 |
Indiana University
| 4 Jahre |
| Yew Cheung Lee | M | 59 |
Indiana University
| 4 Jahre |
| Gregg Poetz | M | - |
Indiana University
| 4 Jahre |
| Mindy Kline | F | 61 |
Indiana University
| 4 Jahre |
| Caroline Winnett | F | - |
Indiana University
| 3 Jahre |
| Mark A. Paul | M | - |
Indiana University
| 4 Jahre |
| John W. Ryan | M | 94 |
Indiana University
| 16 Jahre |
| Eric Scott Mark | M | - |
Indiana University
| 4 Jahre |
| Jeff A. Gonyo | M | - |
Indiana University
| 4 Jahre |
| Jeffrey Kauffman | M | - |
Indiana University
| 4 Jahre |
| Jeffrey McDonald | M | - |
Indiana University
| 4 Jahre |
| Scott Michael Tracey | M | 56 |
Indiana University
| 4 Jahre |
| Dave Heger | M | - |
Indiana University
| 2 Jahre |
| Steven Christopher Demas | M | - |
Indiana University
| 4 Jahre |
| Stephen Badylak | M | - |
Indiana University
| 3 Jahre |
| Gang Yi | M | 66 |
Indiana University
| 8 Jahre |
| Todd Padgett | M | - |
Indiana University
| 4 Jahre |
| James Button | M | - |
Indiana University
| 3 Jahre |
| Rhonda L. Brauer | F | 64 |
Indiana University
| 3 Jahre |
| Todd R. Lindemuth | M | - |
Indiana University
| 4 Jahre |
| Patrick J. Gniadek | M | - |
Indiana University
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 84 | 84,00% |
| China | 11 | 11,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Daniel Zabrowski
- Persönliches Netzwerk
